APA

Otten J., Flamant F., Rodary C., Brunat-Mentigny M., Dutou L., Olive D., Quintana E. & Voûte P. A. (19890921). Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study). : Cancer chemotherapy and pharmacology.

Chicago

Otten J, Flamant F, Rodary C, Brunat-Mentigny M, Dutou L, Olive D, Quintana E and Voûte P A. 19890921. Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study). : Cancer chemotherapy and pharmacology.

Harvard

Otten J., Flamant F., Rodary C., Brunat-Mentigny M., Dutou L., Olive D., Quintana E. and Voûte P. A. (19890921). Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study). : Cancer chemotherapy and pharmacology.

MLA

Otten J, Flamant F, Rodary C, Brunat-Mentigny M, Dutou L, Olive D, Quintana E and Voûte P A. Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study). : Cancer chemotherapy and pharmacology. 19890921.